Browsing by Author Talbot, Denis

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 1 of 1
Issue DateTitleAuthor(s)Citation
2012Randomized Phase II Study of Dacomitinib (PF-00299804), an Irreversible Pan–Human Epidermal Growth Factor Receptor Inhibitor, Versus Erlotinib in Patients With Advanced Non–Small-Cell Lung CancerBoyer, Michael; Barrios, Carlos; Blackhall, Fiona; Bover, Isabel; et al, Various; Frank, Richard; Heo, Dae Seog; Krzakowski, Maciej; Park, Keunchil; Ramalingam, Suresh; Rosell, Rafael Costa; Talbot, Denis; Central Clinical School: MedicineRandomized Phase II Study of Dacomitinib (PF-00299804), an Irreversible Pan–Human Epidermal Growth Factor Receptor Inhibitor, Versus Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer, Journal of Clinical Oncology, vol.30, 27, 2012,pp 3337-3344